An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion
Bousbib exercised expiring stock appreciation rights while maintaining about 1.4 million shares in total beneficial ownership.
Overview
Chairman and CEO Ari Bousbib reported a sale of about 106,000 shares of IQVIA Holdings Inc. (NYSE:IQV) for total proceeds of $26.1 million in an SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price ($245.51); post-transaction value based on July 29, 2026 market close ($247.56).
Details
IQVIA Holdings Inc. is a premier global provider of life sciences intelligence and services operating across multiple continents. The company maintains a competitive advantage through its integrated platform combining proprietary data, advanced analytics, and extensive clinical research capabilities, enabling clients to optimize drug development timelines and commercialization strategies. With TTM revenue of $17.0 billion and a market capitalization of $38.8 billion, IQVIA has demonstrated strong market positioning and sustained growth momentum.
Source
Originally published at www.fool.com.